Risk Communication Advisory Committee; Notice of Meeting, 20608 [2010-9056]

Agencies

• Food and Drug Administration
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 75, Number 75 (Tuesday, April 20, 2010)]
[Notices]
[Page 20608]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9056]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Risk Communication Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Risk Communication Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on May 6, 2010, from 8 a.m. 
to 5 p.m. and May 7, 2010, from 8 a.m. to 2 p.m.
    Location: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, 
Conference Center (rm. 1503), Silver Spring, MD 20993. Please note that 
all visitors must park in the visitors' parking lot near Building 22 
(for a campus map, see https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/default.htm). The 
Campus is also served by several bus lines connecting to metro rail 
(see https://www.wmata.com/).
    Contact Person: Lee L. Zwanziger, Office of the Commissioner, 
Office of Policy, Planning and Preparedness, Office of Planning, Food 
and Drug Administration, 5600 Fishers Lane, rm. 14-90, Rockville, MD 
20857, 301-827-2895, FAX: 301-827-4050, e-mail: RCAC@fda.hhs.gov , or 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 8732112560. Please call the 
Information Line for up-to-date information on this meeting. A notice 
in the Federal Register about last minute modifications that impact a 
previously announced advisory committee meeting cannot always be 
published quickly enough to provide timely notice. Therefore, you 
should always check the agency's Web site and call the appropriate 
advisory committee hot line/phone line to learn about possible 
modifications before coming to the meeting.
    Agenda: On May 6 and 7, 2010, the Committee will review the state 
of current research in a range of fields relevant to improving risk 
communication at FDA, and discuss applications or gaps for strategic 
planning of risk communication at FDA. For more specific agenda 
information, please visit the following Web site and scroll down to the 
appropriate advisory committee link (https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm), or call FDA Advisory 
Committee Information Line as listed above in the Contact Person 
section of the notice. FDA intends to make agenda information available 
at both these locations no later than 15 days before the meeting.
    FDA intends to make background material available to the public no 
later than 2 business days before the meeting. If FDA is unable to post 
the background material on its Web site prior to the meeting, the 
background material will be made publicly available at the location of 
the advisory committee meeting, and the background material will be 
posted on FDA's Web site after the meeting. Background material is 
available at https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee link.
    Procedure: Visitors to the White Oak Campus must have a valid 
driver's license or other picture ID, and must enter through Building 
1. In order to help speed entrance through security, we request that 
attendees send an email giving their full names to RCAC@fda.hhs.gov 
with the word ``registration'' in the subject line, or telephone Lee 
Zwanziger (see Contact Person), by April 27, 2010.
    Interested persons may present data, information, or views, orally 
or in writing, on issues pending before the committee. Written 
submissions may be made to the contact person on or before May 3, 2010. 
Oral presentations from the public will be scheduled between 
approximately 3:15 p.m. and 4:15 p.m. on May 6, 2010, and between 1 
p.m. and 1:30 p.m. on May 7, 2010. Those desiring to make formal oral 
presentations should notify Lee Zwanziger and submit a brief statement 
of the general nature of the evidence or arguments they wish to 
present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their presentation 
on or before April 27, 2010. Time allotted for each presentation may be 
limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open public hearing session. The contact person will 
notify interested persons regarding their request to speak by April 28, 
2010.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Lee Zwanziger at 
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures 
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 14, 2010.
Jill H. Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-9056 Filed 4-19-10; 8:45 am]
BILLING CODE 4160-01-S